Emmanuelle Dochy – Biography
Last update: May 21, 2026Executive profile
Emmanuelle was Vice President, Tyrosine Kinase Inhibitors Oncology Franchise and Scientific Partnerships Head at Bayer Pharmaceuticals, and Global Lead, R&D Late Development at Sanofi. Emmanuelle Dochy joined Institut Merieux in 2024.
Emmanuelle Dochy is currentlyChief Medical Officer at Transgene - View - Transgene org chart
Create your alert
to follow the career of Emmanuelle Dochy.
Education
Emmanuelle Dochy has a Doctor of Medicine in Internal Medicine Residency Program from Université libre de Bruxelles.
They have also studied at Université libre de Bruxelles :
Find more alumni from Université libre de Bruxelles
More about Emmanuelle Dochy
Selected links
Do you need to know more about Emmanuelle Dochy? More results.
Participate
- Suggest a professional link about Emmanuelle Dochy
- Delete any non-relevant links for Emmanuelle Dochy
Social media
- Emmanuelle Dochy on Google News, X (Twitter), LinkedIn, YouTube
- View the pictures of Emmanuelle Dochy
The colleagues of Emmanuelle Dochy
Company Colleagues
- At Transgene, Emmanuelle Dochy has 27 colleagues including Alessandro Riva (CEO & Chairman), Maya Said (Director)…
Industry Colleagues
- In the Biotechnology industry, Emmanuelle Dochy has 35,919 colleagues in 2,426 companies located in 45 countries. 17,064 executive movements have been recorded in the last 12 months. Learn more about Biotechnology.
Report an error
Update the org chart details of Emmanuelle Dochy.
Get in Touch
Here are a few tips for establishing great contacts.
